Abstract
Herein we give a brief account of the efforts our group made in recent years to discover novel enzymes and utilize them by bioprocess engineering techniques for stereoselective synthesis of various enantiomerically pure chiral chemicals with high value in a greener manner. Included are discussions on oxidoreductases, expoxide hydrolases and glucosidases in whole cells or isolated form from microorganisms or plants.
Keywords: Target-directed discovery, Biocatalysis, Oxidoreductases, Expoxide hydrolases, Glucosidases, Bioprocess engineering, Reductases, Rhodotorula sp. AS2.2241, Bacillus sp. ECU0013, Adzuki Bean Ketone Reductases, Pseudomonas putida ECU1009, Glycolate Oxidase, Alcaligenes sp. ECU0401, Rhodococcus sp. ECU0066, EPOXIDE HYDROLASES
Current Organic Chemistry
Title: Target-directed Discovery and Bioprocess Engineering of New Enzymes for Environmentally Benign Production of High-Value Chiral Chemicals
Volume: 15 Issue: 14
Author(s): Ling Ou, Hui-Lei Yu and Jian-He Xu
Affiliation:
Keywords: Target-directed discovery, Biocatalysis, Oxidoreductases, Expoxide hydrolases, Glucosidases, Bioprocess engineering, Reductases, Rhodotorula sp. AS2.2241, Bacillus sp. ECU0013, Adzuki Bean Ketone Reductases, Pseudomonas putida ECU1009, Glycolate Oxidase, Alcaligenes sp. ECU0401, Rhodococcus sp. ECU0066, EPOXIDE HYDROLASES
Abstract: Herein we give a brief account of the efforts our group made in recent years to discover novel enzymes and utilize them by bioprocess engineering techniques for stereoselective synthesis of various enantiomerically pure chiral chemicals with high value in a greener manner. Included are discussions on oxidoreductases, expoxide hydrolases and glucosidases in whole cells or isolated form from microorganisms or plants.
Export Options
About this article
Cite this article as:
Ou Ling, Yu Hui-Lei and Xu Jian-He, Target-directed Discovery and Bioprocess Engineering of New Enzymes for Environmentally Benign Production of High-Value Chiral Chemicals, Current Organic Chemistry 2011; 15 (14) . https://dx.doi.org/10.2174/138527211796150598
DOI https://dx.doi.org/10.2174/138527211796150598 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Increasing Testosterone Levels and Effects on Cognitive Functions in Elderly Men and Women: A Review
Current Drug Targets - CNS & Neurological Disorders Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Innovative Research Financing for the 21<sup>st</sup> Century: A Case Narrative in How Technology Transfer and Entrepreneurship Supported the Development of a Prototype Cognitive Prosthetic
Technology Transfer and Entrepreneurship (Discontinued) N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders
CNS & Neurological Disorders - Drug Targets Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
Current Medicinal Chemistry Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Synthesis, Antimicrobial Evaluation and Docking Study of Novel Thiosemicarbazone Clubbed with 1,2,3-Triazoles
Current Bioactive Compounds Hypopituitarism in the Elderly: Multifaceted Clinical and Biochemical Presentation
Current Aging Science Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia
Current Cancer Drug Targets Neurotoxins: Free Radical Mechanisms and Melatonin Protection
Current Neuropharmacology Current Anti-Inflammatory Therapies and the Potential of Secretory Phospholipase A2 Inhibitors in the Design of New Anti-Inflammatory Drugs: A Review of 2012 - 2018
Current Medicinal Chemistry How Should We Deal with Missing Data in Clinical Trials Involving Alzheimers Disease Patients?
Current Alzheimer Research Antioxidant SkQ1 Alleviates Signs of Alzheimer’s Disease-like Pathology in Old OXYS Rats by Reversing Mitochondrial Deterioration
Current Alzheimer Research The Role of Adenosine in Alzheimers Disease
Current Neuropharmacology Chemopreventive Properties of Tolfenamic Acid: A Mechanistic Review
Current Medicinal Chemistry (Iso)Flav(an)ones, Chalcones, Catechins, and Theaflavins as Anticarcinogens: Mechanisms, Anti-Multidrug Resistance and QSAR Studies
Current Medicinal Chemistry Depression Rises the Risk of Hypertension Incidence: Discussing the Link through the Ca2+/cAMP Signalling
Current Hypertension Reviews Fibromyalgia
Current Rheumatology Reviews Transcription Factors in Autoimmune Diseases
Current Pharmaceutical Design Opioid Use and Ventilator-Associated Pneumonia
Current Respiratory Medicine Reviews